RBR-9p66gk已完成未知
utritional follow-up in patients with head, neck and esophageal Cancer undergoing radiotherapy treatment (chemo)
Sheila Cristina Pootz0 个研究点开始时间: 2019年9月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 100Y（—）
入选标准
- •Diagnosis of head and neck or esophageal cancer; individual does not have another catabolic disease such as HIV or cirrhosis; both genders; age between 18 and 100 years.
排除标准
- •Age under 18 years; carrier of another catabolic disease such as cirrhosis or HIV; tumor located in different region of head and neck or esophagus.
研究者
相似试验
招募中
不适用
ymphoscintigraphy in head and neck patients treated with primary radiotherapyhead and neck cancerhead and neck squamous cell carcinoma10038666NL-OMON31486Vrije Universiteit Medisch Centrum20
尚未招募
1 期
A Pilot Study of Cetuximab Radiolabelled with Gallium-68, Lutetium-177 or Rhenium-188 as a Novel Radioimmunotherapy for Advanced Head and Neck Cancer: A New Adjunct to Multi-modality Treatment.Head and Neck Squamous Cell CarcinomaCancer - Head and neckACTRN12614000491662Dr Timothy Marr30
尚未招募
不适用
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in a prior clinical study.Renal transplant rejectionAllograft rejection1002766510029149NL-OMON56013Sangamo Therapeutics France SAS8
进行中（未招募）
1 期
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg therapy, TX200-TR101) in a prior clinical study.Prevention of immune mediated allograft rejection in patients with end-stage renal disease (ESRD) who are tissue typed as HLA-A*02 negative and have received a kidney transplant from an HLA-A*02 positive living donor.MedDRA version: 21.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2022-002440-40-DESangamo Therapeutics France SAS15
招募中
不适用
utritional Aspects in Head and Neck Cancer Patients undergoing Radio(chemo)therapyC00-C14R64Malignant neoplasms of lip, oral cavity and pharynxCachexiaDRKS00016862Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf70